Spectrum Pharmaceuticals, Inc. Reports Fourth And Full Year 2013 Financial Results
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today financial results for the three-month period and year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.